Lipids and atherogenesis in diabetes mellitus

Atherosclerosis

Volumn 124, Issue SUPPL., 1996, Pages

  Betteridge, D John ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Arterial endothelial function; Atherosclerosis; Diabetes; Dyslipidaemia

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTERY ENDOTHELIUM; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY RISK; DIABETES MELLITUS; DYSLIPIDEMIA; HUMAN; LIPID TRANSPORT; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0029757469     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(96)05856-X     Document Type: Conference Paper

References (42)

1. Diabetes Care and Research in Europe: the St. Vincent Declaration Action Programme. Krans HMJ, Porta M and Keen H. (eds.). Copenhagen: WHO Regional Office for Europe, 1992.
2. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors and 12-year cardiovascular mortality for men screened in the MRFIT trial. Diabetes Care 1993;16:434.
3. Celermajer DS, Sorensen KE, Gooch V, Spiegelhalter DS, Miller O, Sullivan I, Lloyd J, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340:1111.
4. Sorensen KE, Celermajer DS, Georgakopoulous D, Hatcher G, Betteridge DJ, Deanfield JE. Impairment of endothelial dependent dilatation is an early event in childen with familial hypercholesterolaemia and is related to the lipoprotein(a) level. J Clin Invest 1994;93:50.
5. Levine GN, Keaney JF, Vita JA. Cholesterol reduction in cardiovascular disease - clinical benefits and possible mechanisms. N Engl J Med 1995;332:512.
6. Nabel EL, Selwyn AP, Ganz P. Large coronary arteries in humans are responsive to changing blood flow: an endothelium-dependent mechanism that fails in patients with atherosclerosis. J Am Coll Cardiol 1996;16:349.
7. Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish CB, Yeung AC, Venssen V, Selwyn AP, Ganz P. Coronary vasomotor responses to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990;81:491.
8. Uehata A, Gerhard MD, Meredith IT, Lieberman EL, Selwyn AP, Creager M, Polak J, Ganz P, Yeung AC, Anderson TJ. Close relationship of endothelial dysfunction in coronary and brachial artery. Circulation 1993;88(Suppl I):I-618.
9. Clarkson P, Celermajer DS, Yue DK, Betteridge DJ, McCredie R, Robinson J, Bonney MA, Donald AE, Powe AJ, McCarthy S, Deanfield JE. Endothelial dysfunction in insulin dependent diabetes relates to the duration of disease and the LDL cholesterol level. Circulation 92(Suppl I):I-107.
10. Calver AL, Collier JG, Vallance PJT. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 1992;90:2546.
11. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 1993;88:2510.
12. Consensus statement. Detection and management of lipid disorders in diabetes. Diabetes Care 1993;16:106.
13. The Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383.
14. Betteridge DJ. Diabetic dyslipidaemia. Am J Med 1994;96(Suppl 6A):25S.
15. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin resistance syndrome (syndrome X). Diabetes 1992;41:715.
16. Laakso M. Epidemiology of diabetic dyslipidaemia. Diabetes Rev 1995;3:408.
17. Stern MP, Mitchell BD, Haffner SM, Hazuda HP. Does glycaemic control of type II diabetes suffice to control diabetic dysliidaemia. A community perspective. Diabetes Care 1992;15:638.
18. Howard BV. Pathogenesis of diabetic dyslipidaemia. Diabetes Rev 1995;3:423.
19. Hulley SB, Rosenman RH, Bawal RD et al. Epidemiology as a guide to clinical decisions: the association between triglyceride and coronary heart disease. N Engl J Med 1980;302:1383.
20. Hokanson JE, Austin MA. Triglyceride is a risk factor for coronary disease in men and women: a meta analysis of population-based prospective studies. Circulation 1993;88(Suppl):I-510.
21. Assmann G, Schulte H. Relation of high density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Am J Epidemiol 1992;70:733.
22. Manninen V, Tenkanen L, Koskinen P, et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Circulation 1992;85:37.
23. Mahley RW, Rall SC Jr. Type III hyperlipoproteinaemia (dysbetalipoproteinaemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In: Sriver CR, Beaudet AL, Sly WD and Valle D. (eds.). The Metabolic and Molecular Bases of Inherited Disease, 7th Edn. New York: McGraw Hill, 1995;1953-1980.
24. van Lenten BJ, Fogelman AM, Jackson RJ, et al. Receptor-mediated uptake of remnant lipoproteins by cholesterol laden human monocyte macrophages. J Biol Chem 1985;260:8783.
25. Krauss RM, Lindgren FT, Williams PT, et al. Intermediate density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men. Lancet 1987;ii:62.
26. Lewis GF, O'Meara NM, Soltys PA, et al. Fasting hypertriglyceridaemia in non-insulin dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities. J Clin Endocrinol Metab 1991;72:934.
27. Chen Y-DI, Swami S, Skowronski R, Coulston A, Reaven GM. Differences in postprandial lipaemia between patients with normal glucose tolerance and non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab 1993;76:172.
28. Tan KCB, Cooper MB, Ling KLE, Griffin BA, Freeman DJ, Packard CJ, Shepherd J, Hales CN, Betteridge DJ. Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin dependent diabetic patients with and without hypertriglyceridaemia: precursor species and insulin resistance. Atherosclerosis 1995;113:273.
29. Eisenberg S, Garish D, Oschry Y, Fainaru M, Deckelbaum RJ. Abnormality in very low, low and high density lipoproteins in hypertriglyceridaemia. J Clin Invest 1984;74:470.
30. McNamara JR, Campos H, Ordovas JM, et al. Effect of gender, age and lipid status on low density lipoprotein subfraction distribution, results from the Framingham Offspring Study. Arteriosclerosis Thromb 1987;7:483.
31. Barakat HA, Carpenter JW, McLendon VD, et al. Influence of obesity, impaired glucose tolerance and NIDDM on LDL structure and composition. Diabetes 1990;39:1527.
32. James RW, Pometta D. The distribution profiles of very low density and low density lipoproteins in poorly controlled male type 2 (non insulin dependent) diabetic patients. Diabetologia 1991;34:246.
33. Tilly-Kiesi M, Kuusi SM, Lahdenpera L, Taskinen MR. Abnormalities of low density lipoproteins in normolipidaemia type II diabetic and non-diabetic patients with coronary artery disease. J Lipid Res 1992;33:333.
34. Griffin BA. Low density lipoprotein heterogeneity, In: Betteridge DJ. (ed.). Bailliere's Clinical Endocrinology and Metabolism: Dyslipidaemia. London: Baillière Tindall, 1995;9:687-703.
35. Caslake MJ, Packard CJ, Series JJ, Yip B, Dagen MM, Shepherd J. Plasma triglyceride and very low density lipoprotein metabolism. Eur J Clin Invest 1992;22:96.
36. Reaven GM, Chen Y-DI, Jeffersen J, Maheux P, Krauss RM. Insulin resistance and hyperinsulinaemia in individuals with small dense low density lipoprotein particles. J Clin Invest 1993;92:141.
37. Selby JV, Austin MA, Newman B, et al. LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation 1993;88:381.
38. Stewart MW, Laker MF, Dyer RG, et al. Lipoprotein compositional abnormalities and insulin resistance in type 2 diabetic patients with mild hyperlipidaemia. Arteriosclerosis Thromb 1993;13:1046.
39. Carlson LA, Rosenhamer G. Reduction of mortality in the Stockholm Ischaemia Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid. Acta Med Scand 1988;223:405.
40. Koskinen P, Manttari M, Manninen V, Huttunen JK, Heinonen OP, Frick MH. Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study. Diabetes Care 1992;15:820.
41. Betteridge DJ. Diabetic dyslipidaemia: treatment implications. J Int Med 1994;236(Suppl 736):47.
42. Garg A, Grundy SM. Treatment of dyslipidaemia in patients with NIDDM. Diabetes Rev 1995;3:433.